KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 261,698 Value ($000) $5,163 Avg Close — Range —
Q4 2023
Shares 259,283 Value ($000) $4,548 Avg Close — Range —
Q3 2023
Shares 256,932 Value ($000) $4,463 Avg Close — Range —
Q2 2023
Shares 160,644 Value ($000) $2,262 Avg Close — Range —
Q1 2023
Shares 40,366 Value ($000) $434 Avg Close — Range —
Q4 2022
Shares 22,359 Value ($000) $335 Avg Close — Range —